The headline story is debunking, not danger: you have been sold a "medium-chain" oil that mostly behaves long-chain, a ketone effect that mostly belongs to a different product, and a Pacific-island paradox that mostly comes from eating whole coconuts in a whole-food life. The cholesterol bump from cooking with coconut oil instead of olive oil is real but modest — a quiet drag on your arteries over decades, not a heart attack tomorrow. The action is simple and cheap: keep a jar for flavour, for your skin, and for your hair; reach past it for your everyday cooking fat.
The thing to know about coconut oil is what kind of saturated fat it is, because the whole rest of the story hangs on it. Roughly half of coconut oil is lauric acid — a fatty acid that chemists call "medium-chain" because it has twelve carbon atoms, which falls inside the medium-chain box on a textbook diagram. The body does not read textbook diagrams. When you eat lauric acid, about three-quarters of it gets packaged into the same kind of fat-shuttle (chylomicrons) the body uses for long-chain saturated fats — the ones in butter, in cheese, in beef Eyres 2016. It does not take the express route to the liver that the true short medium-chain fats — caprylic (eight carbons) and capric (ten carbons) — take. It takes the slow road, and the slow road is the same one all the other saturated fats are on.
This matters because the "express route" is the whole reason medium-chain fats got famous. True medium-chain triglyceride oil — the kind sold in bottles labelled MCT oil — is mostly C8 and C10. Those go straight to the liver, turn into ketones, and give you a small clean-burning fuel hit your brain can use. Coconut oil contains only about six to nine per cent of those true medium-chain fats by weight Eyres 2016. The other ~85% is lauric acid plus smaller amounts of myristic and palmitic acid — the saturated fats from butter, but in plant form.
That is the whole "is coconut oil really an MCT?" debate, in one sentence: it contains a little bit of true MCT, and a lot of fat that the marketing claims as MCT on a technicality the gut doesn't recognise.
What it does to your cholesterol
The cleanest read on coconut oil and blood lipids is a 2020 pooled analysis in Circulation of sixteen randomised trials in which people ate coconut oil for at least two weeks while researchers measured what happened to their cholesterol. When coconut oil replaced ordinary plant oils like olive, canola, soybean, or safflower, LDL — the cholesterol your cardiologist asks about — went up by roughly ten milligrams per decilitre. HDL went up by about four. Triglycerides, weight, blood sugar, and inflammation barely moved.
You will sometimes see one 2018 British trial cited as the exception that absolves coconut oil — ninety-four healthy adults, four weeks of fifty grams a day, no statistically significant LDL difference between coconut and olive oil Khaw 2018. It is a real result. It is also a single short underpowered trial against more than a dozen others pointing the other way. The honest read is what the field's main heart association published the year before: coconut oil raises LDL, the LDL rise causes cardiovascular disease, and there is no known offsetting benefit, so use it sparingly Sacks 2017.
What about HDL? Doesn't that cancel out?
Not quite. HDL does go up — that's real. But the ratio of total cholesterol to HDL — the number cardiologists actually use to translate a lipid panel into a risk number — gets worse on coconut oil than on olive or canola, because the LDL rise is larger than the HDL rise Mensink 2003. And the evidence that raising HDL by itself protects the heart has weakened considerably over the last decade. A higher HDL on coconut oil is not a free pass.
What about the ketones? The brain fuel?
Real, but mostly attached to a different product. The good trials on ketone-driven cognitive lift in people with early Alzheimer-pattern decline used a refined drink dosing about thirty grams a day of C8 and C10 — true medium-chain fats — and showed measurable improvements on memory, executive function, and language tests Fortier 2021. To get the same ketone rise from coconut oil, you would need six to eight tablespoons of it every day, dragging the saturated-fat load with it Eyres 2016. The science behind "ketones help certain brains" did not come from the jar in your pantry; it came from the bottle of refined MCT oil at the supplement store, and the two are not interchangeable.
"But Pacific islanders eat tons of coconut and don't get heart disease"
True, and famous. In the 1980s a study of the people of Tokelau and Pukapuka — two small Polynesian atolls — found that they got more than half their calories from coconut, and that clinical heart disease in those populations was rare Prior 1981. A similar picture turned up in coastal Papua New Guinea: the people of Kitava ate coconut, fish, yam, and fruit; stroke and heart attack were almost unheard of Lindeberg 1994.
The catch is that those people were not putting refined coconut oil into bulletproof coffee on top of an otherwise Western diet. They were eating the whole coconut — flesh, water, fibre — as part of a life that included no industrially refined food, no added sugar at scale, no afternoon office chairs, and a level of daily walking and physical labour that would qualify as athletic training where you live. You cannot pull the coconut out of that picture, drop it into a sedentary processed-food diet, and keep the cardiovascular outcome. It is the closest thing to an experiment that confounds itself.
"It's natural and traditional, so it must be fine"
Coconut oil as a household cooking fat for most of the world is not traditional. In coconut-growing regions it has been used for centuries, yes — but the version most readers buy is a refined, deodorised, jar-stable extract that is no more "ancient food" than a bottle of canola. Treat it like what it is: a saturated fat with a particular flavour and a particular skin-care use case.
The stakes are quiet and they show up on paper, not in how you feel. You will not notice the ten-milligram LDL drift from cooking with coconut oil instead of olive oil — that's the whole problem with cholesterol, it doesn't ache. The first time it surfaces is the day your GP frowns at the print-out and asks what you've changed, or the day you and your partner are sat in a cardiology office in your sixties trying to work out which of the things you did for thirty years is the one that ended up mattering.
Years, not weeks. A decade of household-default coconut oil instead of olive oil is the kind of input that nudges you from "boring lipid panel" to "we should probably start a statin," and from "we should probably start a statin" to "you had a small heart attack last Tuesday, lucky it was small" Sacks 2017. The arithmetic is unforgiving and silent. The reverse runs the same way: a year after you swap the household oil back, your next lipid panel is quietly better, your doctor doesn't comment, and nothing in your felt experience has changed at all. That is what winning looks like here. It is not a glow; it is the absence of a slow drag you stopped feeding.
How to actually use it
The rule is two sentences long. Use coconut oil where its flavour does work for you that other oils can't — a Thai or south-Indian curry, a coconut-flavoured baked good, popcorn. Use something else — olive, avocado, high-oleic sunflower or canola — for everything else.
Topical — where coconut oil actually shines
This is the part of the story the dietary debate has buried. Rubbed on the skin, virgin coconut oil works.
The cleanest trial: about a hundred children with mild-to-moderate atopic dermatitis, randomly assigned to virgin coconut oil or mineral oil for eight weeks. Of the kids on coconut oil, ninety-three per cent improved on the standard eczema-severity score; nearly half of those improved by seventy-five per cent or more Evangelista 2014. The mineral-oil group did less well across the board. The skin's water-loss measurement improved too — the barrier was actually working better, not just looking shinier.
For hair, a small but oddly robust 2003 study showed that rubbing coconut oil into hair before washing — and leaving it on for twenty minutes or more — cuts the amount of protein the hair leaks during the wash by as much as forty per cent on damaged hair. Mineral and sunflower oil don't do this; coconut's lauric acid is small enough and the right shape to actually slip into the hair shaft Rele 2003.
The dietary cautions are simple. If you already have heart disease, a strong family history of it, familial hypercholesterolemia, or your last lipid panel showed LDL above your doctor's target — coconut oil as your default cooking fat works directly against everything else you're doing about it Sacks 2017. The occasional teaspoon for flavour is not the problem; the daily tablespoons-in-everything is.
True coconut allergy exists but is uncommon, and it is not the same as a tree-nut allergy despite American food labels lumping them together. If you are tree-nut allergic you are not automatically coconut allergic — but if you have reacted to coconut before, treat both dietary and topical use as off-limits.
A few adjacent threads worth following on their own:
- Olive oil — the everyday cooking fat with the strongest cardiovascular evidence behind it; the natural default once coconut oil is demoted.
- MCT oil (refined C8 / C10) — the actual product behind the ketone and cognitive-fuel claims that get pinned on coconut oil.
- ApoB and the LDL number — the cardiovascular risk number this whole entry quietly turns on.
- Saturated fat in general — coconut oil is one instance of a broader question about butter, cheese, red meat, and palm oil.
- Atopic dermatitis care — the wider routine in which a topical coconut oil smear can sit alongside prescription emollients and trigger avoidance.
Substance and claimed effects
This entry covers coconut as a dietary fat in three forms — fresh or dried coconut flesh, coconut milk (water-extracted from the flesh; canned full-fat is roughly 21 g fat per 100 g, ~half lauric acid), and coconut oil (the extracted fat, ~85–90% saturated). The fatty-acid profile across all three is dominated by lauric acid C12 (~45–53%), with smaller fractions of myristic C14, palmitic C16, and the true medium-chain caprylic C8 and capric C10 at ~6–9% combined Eyres 2016. Topical applications (skin, hair) add a separate evidence stream. Popular claims this entry weighs: that coconut oil is a "healthy saturated fat" because of its medium-chain content; that it produces ketones, fat loss, and cognitive lift comparable to MCT oil; that traditional coconut-eating populations show low cardiovascular disease; and that it is superior to other plant oils for skin and hair.
Evidence by addressing question
Mechanism
Coconut oil's chemistry is the source of most of its confusion. The marketing claim that it is "rich in medium-chain triglycerides" rests on a chemist's definition of medium-chain (C6–C12) that includes lauric acid. Physiologically, however, lauric acid behaves more like a long-chain fatty acid: roughly 70–75% of absorbed lauric acid is packaged into chylomicrons and enters the lymphatic circulation, not the portal vein, where true medium-chain fatty acids (C8, C10) are delivered directly to the liver and rapidly oxidised. This is why coconut oil produces only a small fraction of the ketone elevation seen with refined MCT oil at equivalent dose — only the ~6–9% caprylic + capric fraction takes the fast metabolic route. Eyres 2016 summarises the metabolic distinction.
On lipids: lauric, myristic, and palmitic acid all raise LDL-C when substituted for carbohydrate, with lauric showing the largest concomitant rise in HDL-C of the three. Mensink's meta-analysis of 60 controlled feeding trials quantified this — replacing 1% of energy from carbohydrate with lauric acid raises LDL-C by roughly 1.3 mg/dL and HDL-C by roughly 0.4 mg/dL Mensink 2003. The total-cholesterol / HDL ratio is also worsened relative to unsaturated fats. Coconut oil, being ~50% lauric and ~18% myristic + palmitic, predictably raises LDL through this mechanism.
Evidence
The randomised-trial literature on coconut oil and blood lipids is unusually consistent. Neelakantan et al.'s 2020 meta-analysis in Circulation pooled 16 trials comparing ≥2 weeks of coconut oil to non-tropical vegetable oils, butter, palm oil, or MCT oil. Against non-tropical vegetable oils (olive, canola, safflower, soybean), coconut oil raised LDL-C by about 10.5 mg/dL and HDL-C by about 4 mg/dL; against butter it produced lower LDL; against MCT or palm oils it raised LDL more than MCT but similarly to palm Neelakantan 2020. No effect on triglycerides, body weight, fasting glucose, or CRP was detected. Eyres et al.'s earlier narrative review reached a similar conclusion across 21 papers: coconut oil raises total and LDL-C more than cis-unsaturated plant oils, but less than butter Eyres 2016.
The 2018 Khaw trial in BMJ Open is the cleanest head-to-head: 94 healthy adults randomised to 50 g/day of extra-virgin coconut oil, extra-virgin olive oil, or butter for 4 weeks. Butter raised LDL-C significantly above the other two; coconut oil did not raise LDL-C significantly compared with olive oil in this short, low-power trial, and raised HDL-C more than olive oil Khaw 2018. This single trial is often cited by coconut-oil defenders as exoneration; the larger meta-analytic picture and Teng et al.'s contemporaneous review still land on a net-LDL-raising effect against non-tropical oils Teng 2020.
Hard cardiovascular endpoints — heart attack, stroke, mortality — have not been measured in any coconut oil RCT. The LDL effect is treated as a surrogate; the AHA Presidential Advisory accordingly recommends against coconut oil on the grounds that the LDL rise is causal for cardiovascular disease and the oil offers no offsetting benefit Sacks 2017. This is the source of the field's headline position.
Ecological evidence is loud but weak. The Pukapuka / Tokelau atoll populations, where coconut supplied ~50–60% of daily energy, showed low rates of clinical cardiovascular disease in cross-sectional surveys Prior 1981, and the Kitavan study in coastal Papua New Guinea reported similar findings — leanness, low blood pressure, and rare stroke or ischaemic heart disease in a population where coconut supplied roughly 17% of energy Lindeberg 1994. These are confounded by total physical activity, the absence of refined carbohydrates and processed foods, the whole-coconut-flesh form (high fibre, slow digestion), genetic background, and underdiagnosis. The honest read is that the data don't establish coconut as cardioprotective and don't refute the trial-based LDL signal.
Protocol
For dietary use, the evidence-aligned position is: treat coconut oil as a flavoured saturated fat, not as a primary cooking oil. Used at the ~one-tablespoon-per-day level interchangeably with olive oil for a Thai curry, a baked good, or a stir-fry, it is unlikely to meaningfully shift cardiovascular risk in someone whose overall fat mix favours unsaturated sources. Used as the default cooking and baking fat for an entire household, it adds ~10–15 mg/dL to LDL-C versus olive oil, an effect that compounds across decades of arterial exposure Neelakantan 2020.
Whole coconut flesh (~33 g fat per 100 g, ~9 g fibre) and canned full-fat coconut milk used as recipe ingredients fall into the same bucket: fine as components of a Mediterranean- or whole-food-pattern diet; not a free pass to upscale total saturated-fat intake.
For ketogenic / cognitive-performance protocols specifically, refined MCT oil (C8 or C8/C10 blends) is the right tool, not coconut oil. The dose-equivalent rule of thumb: 6–8 tbsp of coconut oil to match the ketone rise from 1 tbsp of pure C8 Eyres 2016. Fortier et al.'s 6-month RCT in mild cognitive impairment used a ~30 g/day MCT drink (C8 + C10), not coconut oil, and showed improvements on episodic, executive, and language scores Fortier 2021.
Topical: virgin coconut oil applied thinly twice daily as a moisturiser is supported as an effective emollient and barrier-improver for mild-to-moderate pediatric atopic dermatitis Evangelista 2014. As a pre-wash hair treatment applied 20+ minutes before washing, it reduces protein loss from the hair shaft, with effects not matched by mineral or sunflower oil Rele 2003.
Contraindications
Two main groups. Anyone with established cardiovascular disease, familial hypercholesterolemia, or LDL-C above guideline thresholds should avoid coconut oil as a regular cooking fat — the LDL-raising effect adds risk that is otherwise being clinically minimised Sacks 2017. Anyone on lipid-lowering therapy (statins, PCSK9 inhibitors) does not need to fear the occasional teaspoon, but routine use undermines the intervention's effect.
Coconut allergy exists but is rare; cross-reactivity with tree-nut allergies is uncommon despite the FDA classifying coconut as a tree nut for labelling purposes. No evidence of contraindication in pregnancy, breastfeeding, or paediatric topical use at typical doses Evangelista 2014.
Misconceptions
Three high-circulation claims do not survive the evidence:
- "Coconut oil is mostly MCTs." Only ~6–9% by weight is C8/C10; the dominant lauric acid (~50%) is metabolically long-chain in absorption and oxidation kinetics Eyres 2016.
- "Coconut oil raises HDL, so it's net cardioprotective." It does raise HDL by a few mg/dL — but the LDL rise is larger in absolute and risk-weighted terms, and the total-cholesterol / HDL ratio is worse than for olive or canola oils Mensink 2003 Neelakantan 2020.
- "Pacific island populations eat coconut and have no heart disease, so coconut oil is fine." The Tokelau / Kitava data describe whole-food, high-activity, low-processed-carb populations consuming the whole coconut, not refined coconut oil added to a Western diet Prior 1981 Lindeberg 1994. The ecological correlation does not transport to an extracted-oil intervention overlaid on a sedentary Western pattern.
Alternatives
For everyday cooking, extra-virgin olive oil has the strongest cardiovascular outcome evidence (PREDIMED, Mediterranean-pattern trials) and lowers LDL-C versus saturated-fat baselines. For high-heat applications, refined olive, avocado, and high-oleic sunflower or canola sit in a similar lipid-favourable range. For ketogenic / cognitive applications, refined C8 MCT oil dosed at 10–30 g/day delivers the ketone elevation coconut oil only feebly approximates Fortier 2021. For topical skin / hair, the coconut-oil case stands on its own merits and need not be replaced unless tolerance is poor Evangelista 2014 Rele 2003.
Failure modes
Two recurring patterns: (1) the keto enthusiast who tablespoons coconut oil into coffee believing it matches MCT oil's ketone output and lipid neutrality — gets neither the ketone rise nor the lipid pass Eyres 2016. (2) the family that "switches everything to coconut oil" on the strength of social-media health claims, raising household LDL-C exposure by a measurable ~10 mg/dL on average without any offsetting benefit Neelakantan 2020.
Practicalities
Coconut oil is shelf-stable, solid at <24 °C, has a smoke point of ~177 °C for virgin and ~204 °C for refined, and costs roughly the same per litre as olive oil. Flavour-driven uses (Thai curries, baked goods, popcorn) are where it adds something other oils can't match.
Stakes
The lifetime cardiovascular effect of routinely cooking with coconut oil versus olive oil is modest but real. A sustained ~10 mg/dL LDL-C delta, integrated over decades, corresponds to a measurable bump in atherosclerotic cardiovascular disease (ASCVD) risk by population epidemiology — meaningful in someone whose other risk factors are already controlled, larger in someone whose baseline risk is high Sacks 2017 Neelakantan 2020. The effect is silent — felt as none of the usual symptoms — until it isn't.
Payoff
The "use coconut oil thoughtfully, not as a default" payoff is mostly the absence of harm rather than a positive felt effect. Topical use does have a real, felt-experience-scale payoff: softer skin and less protein loss from damaged hair within weeks of consistent use Evangelista 2014 Rele 2003.
History
Coconut was demonised in the 1990s alongside tropical oils generally, then rehabilitated by the keto / paleo movements in the 2000s–2010s on the (partly correct, partly conflated) MCT story, then re-demonised by the 2017 AHA advisory Sacks 2017. The pendulum reflects the field's recurring confusion about lauric acid's classification more than it reflects new data.
The credibility range
Optimist case. Coconut oil raises HDL alongside LDL, which the simple LDL story understates. Cardiovascular outcome trials of coconut oil do not exist — the AHA position rests on a surrogate. The Tokelau, Pukapuka, and Kitava studies describe real human populations consuming coconut at high levels without measurable cardiovascular disease. Lauric acid has antimicrobial properties via monolaurin and may contribute to gut and oral health. The 2018 Khaw trial found no LDL difference between coconut oil and olive oil over 4 weeks Khaw 2018. Topical applications are robustly supported for skin barrier and hair-shaft protection Evangelista 2014 Rele 2003. A modest culinary use within a Mediterranean-pattern diet is unlikely to register on long-term cardiovascular risk.
Skeptic case. Lauric acid is metabolically a long-chain saturated fatty acid that raises LDL-C through the same LDL-receptor down-regulation pathway as palmitic and myristic acid Mensink 2003. The randomised-trial meta-analytic signal against non-tropical vegetable oils is large, consistent, and unambiguous Neelakantan 2020. HDL elevation does not offset the LDL rise: the total-cholesterol/HDL ratio is worse than with unsaturated oils, and Mendelian-randomisation evidence weakens the causal HDL-protective story regardless. The ecological coconut-eating-population data are confounded by physical activity, whole-food diets, lean phenotypes, and underdiagnosis. The MCT halo is largely false advertising — the medium-chain fraction is ~6–9% by weight, and coconut oil cannot stand in for refined MCT oil in either ketogenic or cognitive applications Eyres 2016 Fortier 2021. The honest call from a guidelines body — AHA's — is to use it sparingly Sacks 2017.
Author's call. The skeptic case wins on cardiovascular use as a primary cooking oil; the optimist case wins on topical use and occasional flavoured use. Coconut oil is neither poison nor superfood: it raises LDL-C measurably versus unsaturated oils, the rise has the same causal status for cardiovascular disease as any other LDL rise, and there is no compensating benefit that the larger fatty-acid literature supports. As a flavoured fat used a few times a week, it is a non-issue; as the household default, it is a quiet, decades-long drag on cardiovascular risk. The MCT / ketone story is real for refined MCT oil and only feebly applicable to coconut oil. Controversy is high because the keto / paleo and AHA camps disagree foundationally about saturated fat; evidence on the LDL endpoint is strong (multiple meta-analyses) but on hard endpoints is absent.
Stakeholder and incentive map
- Coconut industry and exporters (Philippines, Indonesia, India, Sri Lanka) — promote coconut oil aggressively as a wellness product; the LDL story is bad for trade.
- Keto / paleo influencer ecosystem — leveraged the MCT-content claim to position coconut oil as a "good saturated fat"; pivoted to true MCT oil as that became commercially available.
- Cardiology guidelines bodies (AHA, ACC, ESC) — anchored to the LDL-CVD causal chain; positioned firmly against coconut oil Sacks 2017.
- Plant-oil industry (canola, soybean, sunflower) — commercial interest in the saturated-fat-is-bad framing.
- Cosmetic and topical-product makers — strong, growing market for virgin coconut oil as skin / hair product; the topical evidence supports the marketing.
Population variability
The LDL response to saturated fat varies roughly two-fold between individuals (hyper-responders vs hypo-responders), partly genetically determined (APOE genotype, LDL-receptor variants). Hyper-responders see proportionally larger LDL rises from coconut oil and proportionally larger drops when they swap to unsaturated oils. Baseline LDL matters: a reader at 80 mg/dL has a different absolute risk delta from 10 mg/dL than a reader at 160 mg/dL. Whole-food, high-fibre, high-activity dietary patterns (the Pacific-island populations' real story) blunt the lipid signal substantially Prior 1981. For topical use, atopic-dermatitis benefit is strongest in mild-to-moderate disease; severe AD needs medical treatment, not oil Evangelista 2014.
Knowledge gaps
- No randomised trial of coconut oil with hard cardiovascular endpoints exists, and given current guideline positions, none is likely. The LDL endpoint is what we have.
- The long-term effect of moderate, intermittent coconut oil use within an otherwise unsaturated-fat-heavy diet has not been studied — most trials run extreme replacement protocols.
- Whether the lauric-acid HDL rise carries any causal cardiovascular protection (versus being a metabolic side-effect with no clinical meaning) is unsettled and bears on the optimist case.
- Population variability in lipid response to coconut oil specifically (not saturated fat generally) is under-studied.
- Topical mechanisms for atopic-dermatitis benefit (antimicrobial vs barrier vs anti-inflammatory) are not fully characterised.
Scope and brief. The brief named LDL, HDL, satiety, ketones, and the contested CV literature. The article covers LDL, HDL, ketones, and the contested CV literature head-on. Satiety is intentionally not given an addressing section. The randomised-trial signal for coconut oil specifically on appetite or weight is null in the Neelakantan meta-analysis, and the MCT-on-satiety literature is inconsistent and dose-sensitive enough that pulling it through to coconut oil would mislead the reader into a benefit the lauric-acid-dominant profile doesn't deliver. Calling that out under misconceptions would have rewarded the false belief with attention; the better move was to address the broader "MCT halo" misconception once and let the satiety claim fall under it.
Action and cadence choice. Chose know over avoid or decide because the entry's deliverable is a mental-model correction the reader then applies at variable triggers (next cooking-oil purchase, next "coconut oil cures X" social post, next eczema flare). avoid would have over-condemned the topical use, which the evidence supports; decide implies clinician input the dietary call doesn't really require for the typical reader. Cadence as-needed rather than daily because the action is awareness applied at irregular decision points, not a repeated daily behaviour.
Rating difficulties.
longevityscored 0, not 1, because the dimension is benefit-only and coconut oil's directional cardiovascular signal versus unsaturated alternatives is mildly adverse. Marking it 0 with a justification that names the LDL signal felt more honest than inventing a positive justification for a non-zero score.controversyat 4 was the call after weighing AHA vs keto-community vs Pacific-island-ecology positions. A 5 felt overstated — there is broad mainstream-cardiology agreement; the dispute is between mainstream cardiology and dissenting subcultures, not within mainstream cardiology itself.beauty_directat 2 rather than 3 because the topical effect is real but conditional on actually using it topically; a dietary reader gets none of it.applicabilityat 4 reflects universal cooking-fat relevance plus the persistent wellness-marketing reach of coconut oil claims; not 5 because coconut oil is not literally a universal substrate the way sleep or sunlight is.
Hard decisions during the write. The Khaw 2018 trial was the closest call. It is genuinely cited by serious people as exoneration. The choice was to name it explicitly and then weight it correctly against the meta-analytic picture rather than pretend it doesn't exist. The dossier carries the full optimist case so a future reviewer can see the bridge.
Separate-entry candidates.
- MCT oil (refined C8 / C10) — a distinct substance with its own dose-response, ketone, and cognitive-impairment evidence. Currently rides as an aside here; deserves its own entry, especially as cognitive-aging tooling.
- Saturated fat as a category — coconut is one face of the broader question; an entry on dietary saturated fat in general would be a natural parent.
- Lauric acid / monolaurin antimicrobial claims — small literature, but real (in vitro and some clinical for skin / oral). Not enough to anchor this entry on; could anchor its own.
Future-link candidates. Once the catalogue carries entries on olive oil, ApoB / lipid panels, MCT oil, statin therapy, and atopic dermatitis care, the out-of-scope list here should be wired to them.
Dream-narrative tier. Overall computed at ~22, well below the 40 floor at which a dream narrative becomes obligatory. Wrote one anyway because the relief / not-being-conned lever is the entry's natural hook, and the dek and tagline are visibly sharper for being written from it. The dek leans on the lauric-acid technicality as the single arresting fact; the tagline crystallises the same lever in three short sentences.
Coconut and Coconut Oil
Bottle of refined coconut oil runs ~$10-15 per litre, comparable to mid-range olive oil; topical jars at similar prices. Trivial annual cost at any realistic use level.
Action is a pantry decision and an occasional cooking-fat swap; topical use is a daily smear. No sustained discipline or lifestyle reorganisation required.
Multiple meta-analyses (Neelakantan 2020 in Circulation; Eyres 2016; Teng 2020) consistently document the LDL-raising effect versus non-tropical oils. The surrogate-endpoint evidence is strong and replicated; hard cardiovascular endpoints have not been tested directly in coconut-oil RCTs (Sacks 2017).
Topical virgin coconut oil halved SCORAD index in mild-to-moderate pediatric atopic dermatitis over 8 weeks (Evangelista 2014), and pre-wash application substantially reduces hair-shaft protein loss versus mineral and sunflower oils (Rele 2003). The effect is real, evidenced, and visible within weeks, but confined to topical use; dietary coconut produces no direct visible effect.
Consistent topical use sustains a modest barrier and hair-protein protection over months. There is no internal-health pathway from dietary coconut to a meaningfully different long-term appearance trajectory; the LDL signal trends mildly adverse rather than aesthetically beneficial.
The 6-9% true medium-chain (C8/C10) fraction produces a modest ketone elevation, but ~6-8 tbsp of coconut oil would be needed to match 1 tbsp of refined MCT oil's ketone rise (Eyres 2016). Energy effect at culinary doses is trivial.
Ketone-mediated cognitive effects in mild cognitive impairment were demonstrated with a refined MCT drink, not coconut oil (Fortier 2021). At typical dietary intake, coconut oil produces only a small cognitive lift via the same mechanism, far below the MCT-oil effect.